Please Download the ZIP File Below
If you’re a journalist researching Kloxxado®, opioid overdose, fentanyl or naloxone in your community, please email communityhealth@hikma.com.
![Kloxxado Device](https://kloxxado.com/wp-content/uploads/2023/04/Kloxxado-Device.png)
US FDA Approves Kloxxado® (naloxone HCl) Nasal Spray 8 mg to Treat Opioid Overdose
Hikma Pharmaceuticals announced, on April 30, 2021, the US Food and Drug Administration (FDA) approval of Kloxxado® (naloxone HCl) Nasal Spray 8 mg, a new opioid overdose reversal medication.
![Young woman working at home young mixed race woman looking at a laptop](https://kloxxado.com/wp-content/uploads/2021/07/Accidental-Overdose-Naloxone-opioid-overdose-resources.jpg)
Frequently Asked Questions
Learn more about Kloxxado® by exploring common patient and caregiver questions.